The aggressive peripheral T-cell lymphomas: 2015

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

(2014) E. R. Parrilla Castellar et al.   BLOOD

Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma

(2014) Cinzia Pellegrini et al.   ONCOLOGIST

Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders

(2013) S. K. Story et al.   ONCOLOGIST

Stem-cell transplantation in T-cell non-Hodgkin's lymphomas

(2011) C. Hosing et al.   ANNALS OF ONCOLOGY

High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma (PTCL): Analysis of Prognostic Factors

(2011) Auayporn Nademanee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

(2011) H. Kimura et al.   BLOOD

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

(2011) R. L. Piekarz et al.   BLOOD

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

(2011) J. Delabie et al.   BLOOD

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

(2011) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

(2011) Owen A. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Crizotinib in Anaplastic Large-Cell Lymphoma

(2011) Carlo Gambacorti-Passerini et al.   NEW ENGLAND JOURNAL OF MEDICINE

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group

(2010) X. Cahu et al.   ANNALS OF ONCOLOGY

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

(2010) M. Sieniawski et al.   BLOOD

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2010) N. Schmitz et al.   BLOOD

Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma

(2010) Giovanni Storto et al.   BRITISH JOURNAL OF HAEMATOLOGY

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

(2010) Greg Dueck et al.   CANCER

Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review

(2010) Mark G. Ochenrider et al.   Clinical Lymphoma Myeloma & Leukemia

Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial

(2010) Marie-Cécile Le Deley et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

(2009) G. S. Falchook et al.   ANNALS OF ONCOLOGY

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

(2009) R. Suzuki et al.   ANNALS OF ONCOLOGY

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

(2009) J. Iqbal et al.   BLOOD

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma

(2009) Laurence de Leval et al.   BRITISH JOURNAL OF HAEMATOLOGY

Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2009) Charalampia Kyriakou et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology

(2009) Laurence Brugières et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies

(2008) Pek-Lan Khong et al.   ANNALS OF HEMATOLOGY

Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab

(2008) D. Aguiar Bujanda   ANNALS OF ONCOLOGY

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine

(2008) G. Jaeger et al.   ANNALS OF ONCOLOGY

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

(2008) N. Mourad et al.   BLOOD

Anaplastic Large-Cell Lymphoma in Women With Breast Implants

(2008) Daphne de Jong   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

(2008)   JOURNAL OF CLINICAL ONCOLOGY

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

(2008) A L Feldman et al.   LEUKEMIA

Case 8-2008

(2008) Jeremy S. Abramson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen

(2007) Siok-Keen Tey et al.   AMERICAN JOURNAL OF HEMATOLOGY